GNFT | Genfit S.A. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.70 - 3.80
52 Week Range	3.31 - 6.42
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	3,174
Average Volume	13,400
Shares Outstanding	49,861,800
Market Cap	189,474,840
Sector	Healthcare
Industry	Biotechnology
IPO Date	2019-03-27

Valuation
Profitability
Growth
Health
P/E Ratio	9.74
Forward P/E Ratio	N/A
EPS	0.39
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	169
Country	France
Website	GNFT

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

GNFT's peers: CLLS, CNTA, DBVT, CYT, ERYP, ELYM, HCWB, MOLN, MNOV, ANEB, CSBR, KROS, JANX, FENC, EWTX, HRMY, AVTE, ADAG, ACRV, RZLT, ANTX, DRTS, SLN, TARS, THTX

*Chart delayed

Analyzing fundamentals for GNFT we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is very good and Health is very weak. For more detailed analysis please see GNFT Fundamentals page.

Watching at GNFT technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on GNFT Technicals page.